Specific defects in DNA repair pathways are reflected by DNA microsatellite instability (MSI) and play an important role in carcinogenesis. Reported frequencies in gastric non-Hodgkin's lymphomas (NHL) vary from 14% to as high as 90%. Another form of genetic instability in tumours is allelic imbalance (AI) due to loss or gain of genetic material at a specific chromosomal region. This might point to the presence of a tumour suppressor gene or oncogene. We examined both MSI and AI in 26 gastric lymphomas (10 low-grade and 13 high-grade MALT lymphomas and three cases lacking MALT features and categorised as diffuse large B cell lymphoma (DLCL)). Tumour components and normal cells (epithelium, muscle) were microdissected from paraffin-embedded resection samples. Contrary to other studies we did not observe frequent MSI when investigating 18 different loci distributed over 12 chromosomes. Microsatellite instability of a single locus was found in 1/10 (10%) low-grade MALT lymphomas and 2/13 (15%) highgrade MALT lymphomas. These data indicate that DNA mismatch repair genes do not play a role in the pathogenesis of these lymphomas. Allelic imbalance was detected in 60% (6/10) of low-grade MALT lymphomas, in 62% (8/13) of high-grade MALT lymphoma and in 67% (2/3) of DLCL. In high-grade lymphomas more loci showed AI (one to seven loci, with a mean of 2.5 loci per case) than in the low-grade lymphomas (one to two loci, with a mean of 1.3 loci per case), possibly reflecting an increased genomic instability.
Introduction
Non-Hodgkin's lymphomas (NHL) of the stomach comprise lymphomas resembling mucosa-associated lymphoid tissue (MALT lymphomas) -ranging from low-grade to high-gradeand lymphomas lacking MALT features (large B cell lymphomas). MALT is normally not present in the stomach but can arise in an environment of Helicobacter pylori-induced chronic gastritis. MALT lymphocytes possibly undergo a sequence of genetic events, ultimately leading to high-grade MALT lymphoma. The continuous proliferation of B cells might facilitate the induction of genetic damage. Accumulation of genetic damage might especially occur in the case of (acquired) defects in DNA repair and this cascade of events might be directly related to the induction of tumour progression.
in the DNA mismatch repair pathway, has been reported in frequencies ranging from 14% to as high as 90%. [9] [10] [11] These values contrast with other types of NHL, where MSI is uncommon, and indicate a possible role for an impaired DNA-repair mechanism in the pathogenesis of MALT lymphomas. MSI, which was discovered in colorectal cancer in 1993 and appeared to be specifically related to hereditary non-polyposis colorectal cancer, is characterised by an altered number of repeat units that constitute DNA microsatellite repeats in tumour DNA. 12, 13 These repeats can occur in both coding and non-coding sequences.
Another form of genetic instability in tumours is allelic imbalance (AI). Due to loss or gain of genetic material at a specific chromosomal region on one of both alleles of the tumour cells, these cells show an altered ratio of both alleles when compared with corresponding normal tissue. This might point to the presence of a tumour suppressor or, in case of amplification, an oncogene. Allelic imbalance of parts of chromosomes has been shown in B-NHL [14] [15] [16] including gastric lymphomas. 10, 17 To investigate genetic instability in gastric lymphomas we examined MSI and AI in gastric resection samples with lowgrade MALT lymphoma, high-grade MALT lymphoma or DLCL. Areas with normal cells (epithelium, muscle) and tumour cells were microdissected from paraffin-embedded tissue. Using PCR technology we investigated 18 different loci distributed over 12 chromosomes, including the marker panel recommended for analysis of colorectal neoplasms, 18 a repeat sequence in the coding domain of BAX (a pro-apoptotic protein belonging to the Bcl-2 gene family) and loci reported by other groups to be involved in MSI in NHL.
Materials and methods

Tissue specimens
Formalin-fixed, paraffin-embedded tissue of surgically resected gastric lymphomas of 26 patients were retrieved from the files of the Department of Pathology of the Leiden University Medical Center, the Netherlands, and from the Department of Clinical Pathology, General Hospital, Vienna, Austria. Ten of these were classified as low-grade MALT lymphoma, 13 as high-grade MALT-lymphoma (seven of which contained separate fields of low-and high-grade tumour cells in the same tissue block) and three were classified as diffuse large B cell lymphoma (DLCL). Criteria described by Isaacson et al [19] [20] [21] were used for the classification. MALT lymphoma was defined by the presence of a small cell component showing reactive follicles surrounded by centrocyte-like cells, plasma cell differentiation and lymphoepithelial lesions. High-grade MALT lymphomas were characterised by the additional presence of sheets of large B cells (centroblasts and immunoblasts). DLCL was defined as lymphoma consisting of large B cells, but lacking features of a low-grade MALT component. The presence of the tumour cells and tumour type were evaluated in each tissue block on haematoxylin and eosin-stained slides that were cut before and after the sections used for DNA isolation. Sections of the same tissue blocks of all but one of the cases included in this study have been stained with a T and B cell marker (respectively CD3 and CD79A) for another study. The percentage of T cells did not exceed 30%.
DNA preparation
Paraffin sections (12 m) were deparaffinised with xylene and stained with haematoxylin and eosin. Before dehydration, tumour and normal (= epithelial and smooth muscle) cell populations were microdissected separately with a needle under microscopic observation. To ensure a high tumour percentage, areas with at least 80% tumour cells were microdissected. DNA was extracted from 10-15 sections according to a method described by Isola et al 22 and Kersemaekers et al. 23 In short, tissue was suspended in 500 l DNA extraction buffer (100 mM NaCl, 10 mM Tris-HCl; pH 8.0, 25 mM EDTA; pH 0.8, and 0.5% sodium dodecyl sulphate). After addition of an aliquot of 30 l proteinase K (10 mg/ml; Sigma, St Louis, MO, USA), samples were incubated at 56°C for 72 h. After 24 and 48 h, fresh aliquots of 20 l proteinase K were added. DNA was extracted with phenol/chloroform/isoamyl alcohol and precipitated with 2.5 volumes of ice-cold 100% ethanol, 0.1 g/l glycogen and 5/8 volume ammonium acetate (7.5 M). DNA was dissolved in TE buffer (10 mM Tris, 0.1 mM EDTA, pH 7.6).
To examine the quality of the microdissected material and the presence or absence of clonal B cells of each case, DNA of tumour area(s) and normal cells was subjected to CDR3-PCR clonality analysis of the immunoglobulin VH-gene using framework 3 and JH primer as described previously. 24 Monoclonality was found in 73% (24/33) of the microdissected tumour samples while polyclonality was found in 21% (7/33) of these samples. Six percent (2/33) of the tumour samples were not evaluable. In the DNA samples obtained from microdissected normal tissue either no product (indicating the absence of B cells) or a polyclonal pattern (due to the presence of some B lymphocytes intermingled with the epithelial and/or muscle cells) was observed, but none of these samples contained a monoclonal population (data not shown). These data are in agreement with expected rates of monoclonality detectable with CDR3-PCR in MALT lymphomas. [24] [25] [26] This PCR analysis indicated that the majority of microdissected tumour DNA used for the MSI/AI analysis indeed represents lymphoma cells and that the samples used as normal controls were not contaminated with a detectable level of lymphoma cells. In three of the eight cases that did not show monoclonality we previously found numerical chromosomal aberrations (investigating the same tissue samples) 6 indicative of the presence of tumour cells in these samples.
Microsatellites
Primer sets were used for the amplification of 18 different microsatellite loci distributed over 12 chromosomes. Of these loci, 12 belong to our primer set used for investigation of HNPCC kindreds and include the reference panel (BAT 25, BAT 26, D5S346, D2S123 and D17S250) and two alternative loci (BAT 40, D13S175) of the NCI workshop on MSI in colorectal cancer 18 plus five additional loci (D3S2456, D8S1130, D15S1232, D16S752, TP53). This set was complemented with bax, D6S265, TNFa and an extra three from reports on MSI in gastric B-NHL (myc, D3S11, D3S1265). [9] [10] [11] The observed polymorphism rate of markers varied from 0.46 to 0.88 (Table 1) .
Polymerase chain reaction and data analysis
Fluorescent PCR and data analysis were performed essentially as described earlier. [27] [28] [29] In short, PCR's were performed in a volume of 12 l containing 1 l template DNA, 5 pmol of each primer, 0.06 units SuperTaq polymerase (HT Biotechnology, Cambridge, UK), SuperTaq polymerase buffer containing 10 mM Tris·HCl, 1.5 mM MgCl 2 , 50 mM KCl, 0.01% gelatin, 200 M of each dNTP and 0.1 g/l BSA, and 0.2 M fluorescent-dCTP for internal fluorescent labelling. Label R6G-dCTP (green) was used for the amplification of tumour DNA and R110-dCTP (blue) for normal DNA (Perkin-Elmer Cetus, Norwalk, CT, USA). Samples were amplified in a 96-well microtiter plate in a DNA Thermal Cycler 9700 (Perkin-Elmer Cetus) under the following conditions: denaturation for 5 min at 94°C, followed by 33 cycles consisting of 1 min 94°C, 2 min 55°C and 1 min 72°C, and a final extension of 6 min at 72°C. For each primer set, PCR products of tumour DNA and normal DNA were mixed 1:1 and red-coloured GENE-SCAN-500 ROX (Perkin-Elmer) was added as internal DNA size marker. These samples were denatured in formamide loading buffer (3 min at 95°C) and electrophoresed on a 6% denaturing polyacrylamide gel using a DNA sequencer (ABI Prism 377; Perkin-Elmer). Products were visualised as peaks and analysed using GeneScan Analysis Software (PerkinElmer). Each peak was quantified in terms of size (base pairs), peak area and peak height.
Some loci were amplified using radioactive PCR technology as described by Weber and May. 27 It resembles the above described method of fluorescent PCR, but instead of the addition of unlabelled dNTPs and fluorescent-dCTPs the PCR reaction mix (12 l) was supplemented with unlabelled dNTPs (lacking dCTPs) and 1 Ci of ␣-
32
-dCTPs (Amersham, Buckinghamshire, UK, specific activity 110 Tbq/mmol) for radioactive labelling of the PCR products. Denatured PCR samples were loaded on a 6% denaturing polyacrylamide gel and PCR products were visualised by autoradiography. All autoradiographs were scanned using a Phosphorlmager 445 SI (Molecular Dynamics, Sunnyvale, CA, USA) so that PCR products were depicted as peaks that could be quantified.
MSI was recorded when novel peaks or peak shifts appeared in tumour DNA samples when compared with matched DNA samples of normal cells. Following the recent workshop on MSI for colon cancer detection 18 MSI-high tumours were defined as having instability of two or more markers of the reference panel (recommended for colorectal neoplasms and consisting of the markers BAT25, BAT26, D2S123, D5S346 and D17S250) or, when investigating more markers, as having MSI in у30-40% of the markers tested. MSI-low tumours were defined as having instability of one marker of the reference panel or of Ͻ30-40% of the markers when investigating a larger panel. MSI-stable cases did not have instability in any of the markers tested. Allelic imbalance (AI) was recorded when the ratio of the peak heights of both alleles of the tumour sample divided by the ratio of both normal alleles was equal to or exceeded a value of 1.7. MSI and AI detected in samples were confirmed by duplicate PCR experiments. Overview of chromosomal location, type of repeat, reported and observed rate of polymorphism and primer sequences (for the Al analysis only the 14 markers marked with * were used; for MSI all markers listed were investigated). Data retrieved from the Genome Database; http//www.gdb.org/gdb-bin/.
PCR template DNA
To test the optimal amount of template DNA we performed a dilution experiment. Two lymphoma samples and matched normal controls (cases 6 and 9) were diluted 2, 5, 10, 50, 100, 200, 500, 1000, 1500 and 2000 times, and all dilutions, including the undiluted sample, were radioactively amplified with marker D3S1265 (Figure 1; case 6) . We noticed the appearance of random, not reproducible bands in highly diluted samples (Figure 1 ). Throughout the study we therefore used template DNA that was maximally 10-fold diluted.
BAX-mutation analysis
Mutation analysis of the BAX gene was performed on RNA samples isolated from frozen tissue of eight gastric lymphomas (three high-grade MALT (cases 11, 18 and 23) and one DLCL (case 24) included in the MSI/AI study, plus four high-grade MALT lymphomas not analysed further for MSI/AI) as described by Meijerink et al. 30 RNA was isolated from frozen sections using TRIzol (GIBCO, Grand Island, NY, USA) and chloroform extraction according to the manufacturer's instructions. Using reverse transcription-PCR and oligo dT, cDNA was obtained which was used as template for the amplification of ␤2 microglobulin (as a control for the RNA isolation) and exon 1 to exon 4/5 of bax. The bax PCR product was analysed on a 5% PAA gel (1:30, in 0.5 × TBE buffer). Next, the bax-␣ product was excised from the gel and eluted to prevent the amplification of several splice-variants in the second amplification step. The eluted product was radioactively amplified and loaded on to an SSCP gel (two conditions: 5% glycerol PAA (49:1) in 0.5 × TBE or in 1 × TPE buffer) and evaluated after exposure of the gel to X-ray film (Eastman Kodak, Rochester, NY, USA).
Results
Markers
PCR assays for MSI analysis were performed with 17 different markers on 33 samples from 26 gastric lymphoma cases. Of these 561 reactions, 523 resulted in evaluable data (=93%). In the other cases PCR reactions failed in either the normal or tumour sample or results were not interpretable. Per lymphoma case at least 10 markers were informative. Each marker was successfully amplified for MSI in at least 70% of the cases. Allelic imbalance of a marker can only be evaluated if the individual under study is heterozygous for that specific marker. Of all 462 PCR reactions performed for AI analysis (14 markers on 33 samples) 409 were technically evaluable (= 89%) for both normal and tumour tissue, with six to 13 heterozygous markers per lymphoma case. PCR products of each marker resulted in informative AI data in at least 70% of the lymphomas.
Microsatellite instability
Screening 33 gastric lymphoma samples from 26 patients with 17 different microsatellite markers we found microsatellite instability for a single locus in only three lymphomas (Table  2 and Figure 2 ). The loci involved were MYC (a dinucleotide repeat) in a case of low-grade MALT lymphoma (1/10) and D15S1232 (a tetranucleotide repeat) in two cases of highgrade MALT lymphoma (2/13) (respectively, cases 10, 19 and 20) . Abnormal bands were detected in a radioactive or fluorescent PCR assay (Figures 3 and 4) .
BAX mutations
In none of the eight gastric lymphomas (cases 11, 18, 23, 24 and four cases not included in the MSI/AI series) investigated with SSCP for bax gene mutations evidence for nucleotide insertions or deletions in the (G)8 tract were detected. Furthermore, none of the cases showed point mutations.
Allelic imbalance
Screening 26 lymphomas with 14 polymorphic markers we found allelic imbalance in 60% of low-grade MALT lymphomas (6/10), in 62% of high-grade MALT lymphomas (8/13) and in 67% of DLCL (2/3) ( Table 2 and Figure 2 ). In total, 8% of all informative low-grade MALT lymphoma PCR samples showed AI (8/101) vs 16% of the high-grade MALT lymphoma PCR samples (20/127) and 32% of the DLCL PCR samples (8/25) . Thirteen of the 14 loci investigated were involved in AI. In the six low-grade MALT lymphomas imbalance was found at eight loci: in four lymphomas at one locus and in two lymphomas at two loci. In the eight high-grade MALT lymphomas with AI, 20 loci were involved: one locus in three lymphomas and two to five loci in the other five lymphomas. Of the two DLCL cases with AI, one lymphoma showed AI for one locus while the other case showed AI for seven loci.
Discussion
Of 26 gastric lymphomas screened for MSI with a panel of 18 different microsatellite markers only three showed instability, each for a single locus. None of the investigated cases showed MSI for one of the five markers that belong to the 'working reference panel' recommended for investigation of colorectal neoplasms. 18 Data suggest that this panel will identify tumours associated with defects in the two major mismatch repair genes hMSH2 and hMLH1. 31 Using the evaluation criteria accompanying the workshop's recommendation none of the 26 investigated cases, neither displaying a MSI-low nor MSIhigh phenotype, meet with the criteria of MSI-positive tumours. 18 Involvement of the DNA mismatch repair genes hMLH1 and hMSH2 is therefore unlikely. These data are consistent with studies indicating that microsatellite instability and mismatch repair deficiency are rare in various non-Hodgkin's lymphomas. 32, 33 Recently, however, various studies suggested an association between MSI and certain subsets of lymphoid malignancies. These specifically include chronic infection and/or inflammation-related lymphomas such as Epstein-Barr virus (EBV)-associated lymphomas in AIDS patients and posttransplant patients as well as the EBV and Herpes Simplex Virus/HH8-associated body cavity lymphomas in AIDS patients. [34] [35] [36] Either the inflammatory reaction itself or products produced by the pathogen (such as reactive oxygen species) induce DNA damage. Combined with a (acquired or inherited) failure in the DNA mismatch repair mechanism, this might result in an instable genome in the tumour cells. This has been described for schistosomiasis 37 and chronic ulcerative colitis. 38 Such a scenario might also apply for the occurrence of MALT lymphoma in the stomach. This lymphoma type is thought to evolve from Helicobacter pylori-associated chronic gastritis. In this background of chronic gastric inflammation the level of DNA damage, induced by, eg oxygen radicals or oxidative stress, might exceed the capacity of the DNA repair mechanisms. Indeed, high incidences of MSI in gastric MALT lymphomas have been reported by two groups. Peng et al 9 described MSI in 33/40 MALT lymphomas. Later Chong et al 10 reported instability in 90% of gastric lymphoma cases. In contrast to these studies, others have reported much lower MSI frequencies for this type of NHL. Mateo et al 39 found MSI in only 7/20 lymphomas and Xu et al 11 reported MSI in only 7/33 gastric lymphomas, all involving a single locus. Our findings are in line with these latter reports. It is unlikely that this variation in MSI is due to differences in the markers used by the various groups. The marker set we applied, comprising 18 markers, was based on the international panel used for the screening of colorectal cancers, supplemented with 13 markers, including some from other studies on MALT lymphomas.
9-11 Moreover, with our marker Table 2 Individual and total results of screening 26 gastric lymphomas for MSI and Al with various markers White, homozygous; grey, heterozygous; black, allelic imbalance; black/MSI, microsatellite instability; ne, not evaluable (ie alleles detectable but signal too weak for ratio calculation); ns, no signal. The three BAT markers are monoallelic and therefore only informative for MSI.
Figure 2
Results of screening 26 gastric lymphomas for MSI (white bars) and Al (black bars) with, respectively, 17 and 14 microsatellite markers. Three cases show MSI, all involving one locus, and 15 cases show Al, involving one to seven loci.
set we screened for MSI not only at mono-and dinucleotide repeats but also at tetranucleotide repeats, which appear to be frequently involved in other cancer types. 40 Of note, we used five markers that showed a high level of MSI in the study of Chong et al. 10 Other variables to explain the discrepancies include geographical variation and sample selection. Peng et al, 9 for instance, reported a high incidence of p53 mutations in their MALT lymphomas that also showed frequent MSI, suggesting that p53 abnormality and MSI affect each other. Indeed, Kastan et al 41 showed that cells with mutant p53 genes continued to progress through S-phase after DNA damage, resulting in the proliferation of cells with DNA damage. The splenic marginal zone lymphomas (SMZL) and MALT lymphomas investigated by Mateo et al 39 showed not only low incidences of MSI but also low frequencies of p53 mutation. Similar to this series, in our lymphoma series a low incidence of p53 overexpression as detected by immunohistochemistry was present: in 2/10 low-grade MALT, 3/13 high-grade MALT and 1/3 DLCL (data not shown).
Yet another variable is the methodology used to analyse instability of DNA repeats. Variations in technical approaches and interpretations of the results may lead to different outcomes. All studies are based on PCR techniques. It is essential that, although PCR is a sensitive technique, the starting amount of amplifiable DNA is high enough to obtain reproducible results with this technique. 42 We microdissected our tumour material and detected a monoclonal population in the majority (73%) of the tumour samples with CDR3 clonality analysis, which has a sensitivity of 5-10% (Derksen et al 24 ) . It is unlikely that our negative MSI results are due to underrepresentation of tumour cells in the microdissected samples since, as shown in Table 2 , in MSI-negative cases AI for at least one marker was present in 21/33 DNA samples (18/26 tumours). Contamination of the tumour clone by normal cells and/or other tumour clones has a greater effect on AI analysis than on MSI analysis. To detect AI, the extent of loss or amplification of a wild-type allele of a tumour clone should surmount the presence of the normal copy of this allele. The imbalance can therefore only be recorded if the qualitative difference between the normal and the aberrant alelle is large enough. MSI, however, is unique for the tumour clone and visible as an extra allele that differs in size compared to the allele of the normal cells or other tumour clones. Tests in our laboratory showed that MSI of a particular population can still be detected even if this population represents less than 10% of a pool of DNA (Sieben et al, in preparation). In other words, MSI of a tumour clone can be detected even if this clone is contaminated with 90% other cells.
The frequency of repeat instability can, on the other hand, also be overestimated. Foucault et al, 42 after performing PCR of CA repeats on dilution series of various cell-sorted samples, observed variations in the banding patterns of the repeats when less than 30 cells were PCR amplified. They had no explanation for the apparently preferential amplification of alleles that differ from the wild-type alleles, at low DNA concentrations. We observed the same phenomenon in DNA samples from archival material. A pattern of altered alleles appeared to be inducible at low concentrations of DNA, isolated from microdissected paraffin-embedded or frozen tissue. These patterns were observed when amplifying either di-, trior tetranucleotide repeats ( Figure 1 and Sieben et al, in preparation). It is therefore important to enrich a tumour sample for tumour cells and ensure a high DNA concentration for PCR. The DNA samples from microdissected cells used in this study were either undiluted or maximally 5-to 10-fold diluted.
Another way to investigate mismatch repair deficiency is mutation analysis of coding repeat sequences. Recently, frameshift mutations within a tract of eight deoxyguaniside residues (G8) in the coding sequence of bax (resulting in premature translation termination of BAX) have been found in MSI-positive haematological malignancies, suggesting that loss-of-function of this pro-apoptotic protein of the Bcl-2 gene family might contribute to the development of certain MSIpositive NHL. We investigated bax mutations in exons 1-5 in eight gastric lymphomas, four of which were analysed further for MSI. None of the eight investigated lymphomas harboured mutations in the bax-G8 tract. These findings are in agreement with the low level of MSI detected in our series of gastric lymphomas and suggest that a failure in the mismatch repair mechanism does not play a major role in the lymphomagen-esis of gastric lymphoma. Recently Peng and co-workers 43 also reported a low frequency of bax mutations in a large series of nodal and extranodal NHL, including 62 MALT lymphomas. Of the 112 investigated NHL only two (a low-grade MALT lymphoma and a centroblastic/centrocytic lymphoma) showed a tumour-specific point mutation. Taken together, these data indicate that tumour-associated mutation of the bax gene is a very rare event in common types of (nodal and extranodal) B-NHL, including MALT lymphomas. 43 Besides MSI we investigated the presence of allelic imbalance in the same series of 26 gastric lymphomas. This aberration was present in more than half of the lymphomas, regardless of their type ( Table 2 ). In two high-grade MALT lymphomas of which the low-and high-grade component were investigated separately AI detected in the high-grade component was already present in the low-grade component (cases 15 and 17) . The number of loci affected by AI, however, was at least twice as high in the high-grade lymphomas when compared with low-grade tumours. This increase in affected loci was also seen in two cases consisting of separate low-and high-grade tumour fields (cases 15 and 16, Table  2 ). Earlier we noted similar findings investigating numerical aberrations in MALT lymphomas. 6 Our allelic imbalance data confirm earlier reports on MALT lymphomas, 17 marginal zone B cell lymphoma (MZBCL) 44 and various other types of NHL. [14] [15] [16] 45 A relatively low frequency of chromosomal loss was found by Chong and colleagues 10 in their gastric lymphomas with frequent MSI. A sample showing repeat instability, however, is not informative for allelic imbalance anymore. 18 Although in various studies on NHL some regions appear to be preferentially involved in imbalance, [14] [15] [16] 45 no conclusive recurrent regions involved in AI have been identified as yet. Of the 14 loci we investigated, 13 showed allelic imbalance in one or more cases. The different lymphoma types showed more or less similar involvement of the various loci, so no correlation could be found between lymphoma type and affected locus, a finding also noted by Chong et al. 10 In summary, this study shows that microsatellite instability is rare in gastric NHL and that therefore defective DNA mismatch repair genes are likely not associated with these lymphomas. Allelic imbalance due to loss or gain of certain chromosomal regions, however, occurs in gastric MALT lymphomas and gastric DLCL. The finding that in the high-grade lymphomas twice as many loci were affected by allelic imbalance as compared with the low-grade cases suggests that the accumulation of genetic alterations is correlated with progression of the disease.
